De Cass Review: een keerpunt in de jeugdgenderzorg
In 2024, an independent review of youth gender care in England concluded that the scientific foundation for puberty blockers and rapid social transition is remarkably weak. The findings have prompted policy changes across multiple countries and raised questions about evidence-based medical practice in this field.
In 2020, the British NHS commissioned pediatrician Hilary Cass to examine youth gender care in England. The investigation was prompted by explosive growth in referrals to the Tavistock gender clinic: from dozens annually around 2010 to thousands per year by 2020, with a notable shift toward teenage girls without prior childhood gender dysphoria.
The final report of nearly 400 pages appeared in April 2024, based on systematic literature reviews by the University of York. The conclusion was clear: care for these children is built on "remarkably weak evidence."
Key findings included:
- No reliable evidence exists that puberty blockers improve mental health in children with gender dysphoria - The widespread claim that puberty blockers are a neutral, reversible 'pause button' lacks support; virtually all children who begin them progress to cross-sex hormones - For most young people, medical intervention is not the optimal route; puberty-onset gender dysphoria often reflects broader mental health issues, autism, trauma, or sexual orientation struggles - Exploratory psychotherapy was incorrectly labeled as 'conversion therapy'
The NHS closed the Tavistock clinic and reduced puberty blocker prescriptions outside research settings. Sweden and Finland had already reversed course following their own literature reviews. An increasing number of countries are questioning how medical treatment with lifelong consequences proceeded so long without solid scientific foundation.
The report describes a care culture where professional skepticism was suppressed. Clinicians questioning the affirmative model departed or remained silent; those continuing critical inquiry risked disciplinary complaints or accusations of transphobia. Growing waiting lists combined with shortened diagnostic processes occurred alongside activist pressure and media attention, rendering normal scientific correction mechanisms ineffective for years.
Netherlands—birthplace of the 'Dutch protocol'—currently maintains existing practice. Amsterdam UMC references its own research tradition, but critics note that original Dutch studies were small, lacked control groups, and involved a fundamentally different patient population than current admissions. No independent Dutch review modeled on the Cass Review has occurred, which is notable for a treatment whose foundation faces international scrutiny.
For parents of children with gender questions, the Cass Review offers two lessons: first, urgency clouds judgment. The Review recommends comprehensive diagnostics examining depression, autism, trauma, and sexual orientation before medical steps. Second, request data: what outcomes exist for children like yours, how long is follow-up, what is known about bone density and fertility? A provider unwilling to answer these questions disregards professional standards—quality care withstands critical questioning.